Jeffrey Tobias

Risk-adapted targeted intraoperative radiotherapy versus whole-breast radiotherapy for breast cancer: 5-year results for local control and overall survival from the TARGIT-A randomised trial

Jayant S. Vaidya, Frederik Wenz, Max Bulsara et al. · The Lancet · 2013 · 822 citations · Full text

Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial

Jayant S. Vaidya, David Joseph, Jeffrey Tobias et al. · The Lancet · 2010 · 756 citations · Full text

Surgical Oncology, Breast Oncology, Radiation Therapy +7

Mitomycin, Ifosfamide, and Cisplatin in Unresectable Non–Small-Cell Lung Cancer: Effects on Survival and Quality of Life

M.H. Cullen, Lucinda Billingham, C.M. Woodroffe et al. · Journal of Clinical Oncology · 1999 · 448 citations

Long term survival and local control outcomes from single dose targeted intraoperative radiotherapy during lumpectomy (TARGIT-IORT) for early breast cancer: TARGIT-A randomised clinical trial

Jayant S. Vaidya, Max Bulsara, Michael Baum et al. · BMJ · 2020 · 279 citations · Full text

Targeted intra-operative radiotherapy (Targit): An innovative method of treatment for early breast cancer

Jayant S. Vaidya, Michael Baum, Jeffrey Tobias et al. · Annals of Oncology · 2001 · 228 citations

Adaptive Radiotherapy, Radiation Therapy, Early Breast Cancer +9